RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan

被引:13
|
作者
Kameyama, K
Okinaga, H
Takami, H
机构
[1] Keio Univ, Sch Med, Div Diagnost Pathol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Univ Tokyo, Fac Med, Dept Nephrol & Endocrinol, Bunkyo Ku, Tokyo 113, Japan
[3] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo, Japan
关键词
medullary thyroid carcinoma; RET protooncogene; familial cancer;
D O I
10.1016/j.biopha.2004.05.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The familial form of medullary thyroid carcinoma (MTC) is caused by mutations of the RET protooncogene. We registered 60 multiple endocrine neoplasia (MEN) 2A patients, 12 familial non-MEN medullary carcinoma (FMTQ patients, and three MEN2B patients with a confirmed RET germline mutation. All 60 MEN2A patients had RET mutations in a cysteine-rich domain. Seven of the FMTC patients had a mutation in cysteine-rich domain, and the other five had a mutation in codon 768, which encodes a tyrosine-kinase domain. Two of the MEN2B patients had a mutation in codon 918, and one patient had a double mutation, one in codon 804 and the other in codon 806, both of which are all encoded tyrosine-kinase domain. The genotype-phenotype correlations of our data will allow individualized recommendations for the optimal timing of prophylactic surgery. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:345 / 347
页数:3
相关论文
共 50 条
  • [1] RET oncogene mutations in a large Korean kindred with familial medullary thyroid carcinoma
    Lee, Y.
    Park, H.
    Jung, J.
    Lim, Y.
    Uchino, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] RET oncogene mutations in medullary thyroid carcinoma in Mexican families
    González, B
    Salcedo, M
    Medrano, ME
    Mantilla, A
    Quiñónez, G
    Benítez-Bribiesca, L
    Rodríguez-Cuevas, S
    Cabrera, L
    de León, B
    Altamirano, N
    Tapia, J
    Dawson, B
    ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (01) : 41 - 49
  • [3] Mutations in the RET proto-oncogene in medullary thyroid carcinoma
    Hoeppner, Wolfgang
    CLINICAL LABORATORY, 2007, 53 (5-6) : 283 - 284
  • [4] RET oncogene mutations in Serbian patients with thyroid medullary carcinoma
    Neskovic, GG
    Veljkovic, E
    Dzodic, R
    Dimitrijevic, B
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 107 - 107
  • [5] Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma
    Marsh, DJ
    Andrew, SD
    Eng, C
    Learoyd, DL
    Capes, AG
    Pojer, R
    Richardson, AL
    Houghton, C
    Mulligan, LM
    Ponder, BAJ
    Robinson, BG
    CANCER RESEARCH, 1996, 56 (06) : 1241 - 1243
  • [6] Prevalence of RET proto-oncogene mutations in medullary thyroid carcinoma
    Gregg, JP
    Chang, AS
    Yamane, AJ
    Grody, WW
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (05): : ST13 - ST13
  • [7] Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
    Wohllk, N
    Cote, GJ
    Bugalho, MMJ
    Ordonez, N
    Evans, DB
    Goepfert, H
    Khorana, S
    Schultz, P
    Richards, CS
    Gagel, RF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10): : 3740 - 3745
  • [8] Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma
    Marsh, DJ
    Learoyd, DL
    Andrew, SD
    Krishnan, L
    Pojer, R
    Richardson, AL
    Delbridge, L
    Eng, C
    Robinson, BG
    CLINICAL ENDOCRINOLOGY, 1996, 44 (03) : 249 - 257
  • [9] Analysis of Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma
    F. A. Amosenko
    V. Zh. Brzhezovskiy
    L. N. Lyubchenko
    M. A. Shabanov
    V. M. Kozlova
    V. E. Vanushko
    T. P. Kazubskaya
    R. F. Garkavtseva
    V. N. Kalinin
    Russian Journal of Genetics, 2003, 39 (6) : 706 - 711
  • [10] Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma
    Magalhaes, PKR
    de Castro, M
    Elias, LLK
    Soares, EG
    Maciel, LMZ
    THYROID, 2004, 14 (10) : 848 - 852